Receptor-mediated in vitro gene transformation by a soluble DNA carrier system
- PMID: 3558345
Receptor-mediated in vitro gene transformation by a soluble DNA carrier system
Erratum in
- J Biol Chem 1988 Jan 5;263(1):588
Abstract
We present, here, evidence that foreign DNA can be specifically delivered to cells by a soluble carrier system that takes advantage of receptor-mediated endocytosis. Our experiments were based on the following concepts: hepatocytes possess a unique receptor that binds and internalizes galactose-terminal (asialo-)glycoproteins; DNA can bind to polycations in a strong but noncovalent manner forming soluble complexes; and the gene for chloramphenicol acetyltransferase, a bacterial enzyme that acetylates chloramphenicol, is not present in mammalian cells. We coupled asialoorosomucoid (ASOR) to poly-L-lysine to form an asialoorosomucoid-poly-L-lysine conjugate. The plasmid, pSV2 CAT, was complexed to the conjugate in a molar ratio of 1:2. To test this complex, a model system was used consisting of hepatoma cell lines, Hep G2, asialoglycoprotein receptor (+), and SK-Hep 1, receptor (-). Each cell line was incubated with filtered ASOR X poly-L-lysine X DNA complex, or controls consisting of DNA plus ASOR, DNA plus poly-L-lysine, or DNA alone. Cells were assayed for the presence of chloramphenicol acetyltransferase activity as a measure of gene transformation. SK-Hep 1, receptor (-) cells, produced no detectable acetylated chloramphenicol derivatives under any condition. However, Hep G2, receptor (+) cells, incubated with the ASOR X poly-L-lysine X DNA complex were transformed as indicated by the presence of chloramphenicol acetyltransferase activity (0.028 chloramphenicol acetyltransferase units/10(6) cells). Mixtures of individual components of the complex failed to transform these cells. Competition by a 10-fold excess of ASOR prevented gene transformation by the ASOR X poly-L-lysine X DNA complex.
Similar articles
-
Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro.Biochemistry. 1988 Feb 9;27(3):887-92. doi: 10.1021/bi00403a008. Biochemistry. 1988. PMID: 2835080
-
Receptor-mediated gene delivery and expression in vivo.J Biol Chem. 1988 Oct 15;263(29):14621-4. J Biol Chem. 1988. PMID: 3049582
-
A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D.Vaccine. 1999 Mar 5;17(9-10):1091-9. doi: 10.1016/s0264-410x(98)00326-0. Vaccine. 1999. PMID: 10195619
-
Delivery systems for gene therapy.Biotherapy. 1991;3(1):87-95. doi: 10.1007/BF02175102. Biotherapy. 1991. PMID: 2009217 Review.
-
The hepatic asialoglycoprotein receptor.CRC Crit Rev Biochem. 1984;16(3):207-33. doi: 10.3109/10409238409108716. CRC Crit Rev Biochem. 1984. PMID: 6383714 Review.
Cited by
-
Calix[4]arene Polyamine Triazoles: Synthesis, Aggregation and DNA Binding.Int J Mol Sci. 2022 Nov 28;23(23):14889. doi: 10.3390/ijms232314889. Int J Mol Sci. 2022. PMID: 36499212 Free PMC article.
-
N4,N9-dioleoyl spermine is a novel nonviral lipopolyamine vector for plasmid DNA formulation.Pharm Res. 2005 Jun;22(6):972-80. doi: 10.1007/s11095-005-4592-1. Epub 2005 Jun 8. Pharm Res. 2005. PMID: 15948041
-
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts.Chem Rev. 2018 Aug 22;118(16):7409-7531. doi: 10.1021/acs.chemrev.7b00678. Epub 2018 Jul 27. Chem Rev. 2018. PMID: 30052023 Free PMC article. Review.
-
Beyond GalNAc! Drug delivery systems comprising complex oligosaccharides for targeted use of nucleic acid therapeutics.RSC Adv. 2022 Jul 14;12(32):20432-20446. doi: 10.1039/d2ra01999j. eCollection 2022 Jul 14. RSC Adv. 2022. PMID: 35919168 Free PMC article. Review.
-
Targeted transfection and expression of hepatitis B viral DNA in human hepatoma cells.J Clin Invest. 1993 Mar;91(3):1241-6. doi: 10.1172/JCI116287. J Clin Invest. 1993. PMID: 8383700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous